Selenium Therapy in Down Syndrome (DS): A Theory and a Clinical Trial-Reference-Cited by-同舟云学术

Selenium Therapy in Down Syndrome (DS): A Theory and a Clinical Trial

Published:1990 Issue: Volume: Page:183-186
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Antila Erkki,Nordberg Ulla-Riitta,Syväoja Eeva-Liisa,Westermarck Tuomas

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4684-5730-8_29

Reference16 articles.

1. Armerén, G., 1984, Down’s syndrome. A metabolic and endocrinological study,Acta Univ.Upps.,Abstracts of Uppsala Disser tations from the Faculty of Medicine,483. 38 pp.,Uppsala.

2. Antila, E., and Westermarck, T., 1989, On the etiopathogenesis of Down syndrome, Int.J.Devel.Biol. (in press).

3. Avraham, K.B., Schickler, M., Sapoznikov, D., Yarom, R., and Groner, Y., 1988, Down’s syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase, Cell, 54:823.

4. Balazs,R.,and Brooksbank,B.W.L.,1985, Neurochemical approaches to the pathogenesis of Down’s syndrome, J.Ment.Def.Res.,29:1.

5. Beuchamp, C. and Fridovich, I., 1971, Superoxide dismutase: improved assays and an assay applicable to acrylamide gels, Anal. Biochem., 44:276

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supplements and Down Syndrome;Dietary Supplements - Challenges and Future Research [Working Title];2022-09-09

2. Reactive Oxygen Species and Selenium in Epilepsy and in Other Neurological Disorders;Personalized Medicine, in Relation to Redox State, Diet and Lifestyle;2020-10-14

3. Personalized Management of Selected Neurological Disorders;Personalized Medicine, in Relation to Redox State, Diet and Lifestyle;2020-10-14

4. Proposed remedies for some developmental disorders;Toxicology and Industrial Health;2012-02-02

5. Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease;Neurobiology of Aging;2007-05